Healthy volunteers test new drug AJ302-IM for safety
Knowledge-focused
Completed
This early-stage study tested a new drug, AJ302-IM, in 57 healthy adults to see if it is safe and how the body processes it. Participants received a single injection of either the drug or a placebo. The goal was to check for side effects and measure drug levels in the blood, not …
Phase: PHASE1 • Sponsor: AnnJi Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC